MTOR and neoplasm: Zhou et al. found that SNORA38B reshapes the tumor microenvironment by regulating the GAB2/AKT/mTOR signaling pathway, reducing tumorigenesis in non-small cell lung cancer and enhancing immune checkpoint blockade [28].